APPLICATION OF ASTASANTINA OF MICROALGAE IN MACULAR DEGENERATION. MIDMAE (Q3214752)

From EU Knowledge Graph
Revision as of 09:21, 21 October 2021 by DG Regio (talk | contribs) (‎Changed an Item)
Jump to navigation Jump to search
Project Q3214752 in Spain
Language Label Description Also known as
English
APPLICATION OF ASTASANTINA OF MICROALGAE IN MACULAR DEGENERATION. MIDMAE
Project Q3214752 in Spain

    Statements

    0 references
    18,706.6 Euro
    0 references
    23,383.25 Euro
    0 references
    80.0 percent
    0 references
    7 October 2015
    0 references
    31 March 2017
    0 references
    NEOALGAE MICRO SEAWEED PRODUCTS
    0 references
    0 references
    0 references

    43°27'16.45"N, 5°51'2.30"W
    0 references
    33035
    0 references
    El proyecto MIDMAE ha estudiado la aplicación de la Astaxantina en relación con los problemas oculares._x000D_ La Astaxantina es un carotenoide liposoluble que se encuentra en la microalga Haematococcus pluvialis y es un antioxidante 10 veces más fuerte que el beta-caroteno y hasta 500 veces más fuerte que la vitamina E._x000D_ La Astaxantina neutraliza los radicales libres, combatiendo enfermedades relacionadas con la edad, como la Degeneración Macular Asociada a la Edad (DMAE), mediante la prevención de la proliferación de estas moléculas inestables. (Spanish)
    0 references
    The MIDMAE project has studied the application of Astaxanthin in relation to eye problems._x000D_ Astaxanthin is a liposoluble carotenoid found in the microalgae Haematococcus pluvialis and is an antioxidant that is 10 times stronger than beta-carotene and up to 500 times stronger than vitamin E._x000D_ Astaxanthin neutralises free radicals, fighting age-related diseases such as Age-Related Macular Degeneration (AMD), by preventing the proliferation of these unstable molecules. (English)
    0 references
    Llanera
    0 references

    Identifiers

    IDE/2015/000810
    0 references